ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2014

Feb 11, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD RESEARCH CORP (ARWR)
CIK: 0000879407
Period of Report: 2014-02-06

Reporting Person: Lewis David L. (Chief Scientific Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-06	Stock Options	$14.54	A	120000	Acquired	2024-02-06	Common Stock (120000)	Direct

Footnotes

F1: Option vests and becomes exercisable after a four year period from date of grant.

F2: Includes shares underlying other options previously granted.